In the last post, I
asserted that much of the growth and potential for 3D in education will find a
promising foothold in medical fields. In this last post, our example reaches into the arena of
patient education.
Patient Education
Chronic Obstructive Pulmonary Disease
(COPD)
is an increasingly global health problem, one which leaves a lot of patient
suffering and costs for care in its wake. Enter Sensavis
CEO, Magnus Arfors, with an aggressive project employing stereoscopic 3D
visualization for patient education.
Together with support from the Karolinska University hospital in
Stockholm and the Swedish public patient insurance organization, this project
may grow into a real game changer.
Graphics from the Sensavis storyboard. Their actual graphics are insanely
realistic.
|
“The overall goal of our effort,” explains
Arfors, “is to educate and motivate patients to take action in the right
direction in order to radically decrease suffering and to save money in the
health care system.” Assembling a team of Sensavis visualization architects,
specialists in lung medicine/physiology, and specialists in patient education,
Arfors is deploying a unique software solution that imitates physiology, both
in healthy lungs and in lungs with COPD (e.g. TLC, FRC, IC, VC, alveolar
pressure, resistance etc.). Using this stereo 3D simulation, physiological
parameters can be changed in real time and the consequences can be explored.
With stereo 3D, the user experience becomes much richer than is the case with
2D visual representation.
The
project will launch with sophisticated content that is presented in large
groups, using a 3D projector. However, their goal is to move well beyond the
traditional scenario we have seen with audience-style patient education. Arfors
plans to enable patients to interact with simpler content themselves, via iPads or tablets—or by making the content available
on the Internet. This self-study approach represents an interesting supplement
to traditional 3D audience-delivery education.
Evaluation
will be a vital part of this project. Sensavis and their university partners
will use a control group methodology to study improvements in learning. They
also aim to analyze the bottom-line—the return on investment in terms of health
improvements and cost savings. Part of the follow up study will measure the
effectiveness of simpler simulations delivered to patients in the self-study
format described above.
Although
some of the collaborators are established, and others (including pharma
companies) are in ongoing discussion, Sensavis is seeking (more) partners for
the financing of the content production and the study. They are also looking
for technical equipment partners (such as screens, projectors, computers and
tablets). If your organization is interested in exploring this opportunity,
please contact Maggie Warbrick at maggie@sensavis.com.
No comments:
Post a Comment